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Abstract: An expeditious synthesis of some 4'-nitrochalcones (3a-n) and their subsequent facile one-pot transformation to 1, 3, 
5-triaryl-2-pyrazolines (4a-n) has been carried out using montmorrilonite K10 via microwave mediated solvent free protocol. 
An emphasis is given to highlighting the greenness of the processes, and a fair comparison is also provided between different 
inorganic solid supports as catalysts. Both conventional as well as non-conventional approaches have been explored by 
comparing the reaction conditions and yields. The newly synthesized pyrazolines were studied for their in vitro antimicrobial 
evaluation against bacterial strains Bacillus pumilus and Escherichia coli and fungal strains Aspergillus niger and Penicillium 
chrysogenum. Findings of biological evaluation highlighted 4b, 4e, 4j and 4m as potential new leads in the search of new 
antimicrobial agents. The structures of newly synthesized compounds have been established on the basis of elemental analysis 
and spectroscopic studies. 
Keywords: Chalcones, Pyrazolines, Montmorrilonite K10, Microwave, Antibacterial activity, Antifungal activity. 
Introduction 
Infectious diseases are one of the major causes of 
death worldwide [1]. During the past decades, new 
infectious disease has appeared and old ones 
previously throughout to be controlled to have 
reemerged and thus, despite many significant 
developments in the antimicrobial therapy, many 
problems remain to be solved for most of the 
antimicrobial drugs available [2]. Hence the discovery 
of new antimicrobial agents will be better 
pharmaceutical profile and is still highly desirable. In 
recent decades, the problems of multi-drug resistant 
microorganism have reached an alarming stage in 
many countries around the world. 
 
*Corresponding author. Tel: (+91) 9414682501, Fax: (+91) 
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Infections caused by the microorganisms need for an 
effective therapy that has led to an escalating search for 
novel antimicrobial agents [3]. 
Small ring heterocycles containing nitrogen, sulphur 
and oxygen have been under investigation for a long 
time because of their pharmacological importance [4]. 
Chalcones possess a wide spectrum of biological 
activities [5-10] offers an unprecedented opportunity to 
synthetic chemists to design different bioactive 
heterocycles due to the presence of α, β-unsaturated 
carbonyl functionality. Nitrogen containing 
heterocycles like pyrazolines have received 
considerable attention in recent years due to their 
varied pharmacological activities such as antiviral [11], 
herbicidal [12], antimicrobial [13, 14], anti-
inflammatory etc. [15].  On the other hand, non-
conventional synthetic routes like inorganic solid 
supported  microwave assisted organic reactions have 
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emerged as a new lead in organic synthesis with 
various advantages like highly accelerated rate of 
reaction, improvement of yield and quality of products 
[16-19]. In continuation of our earlier endeavor [20-22] 
to design and synthesis of novel bioactive heterocycles 
and keeping in view the advantages of heterogeneous 
catalysis for the synthesis of bioactive heterocycles; it 
was felt worth-while to synthesize some novel 
chalcones and their pyrazoline derivatives.  
Results and discussion 
Firstly, a series of substituted 4′-nitrochalcones (3a-
n) has been synthesized using montmorriolonite K10 
as catalyst via Claisen-Schmidt condensation of 4-
nitroactophenone and variously substituted aromatic 
aldehydes. Some of the starting chalcones have been 
reported by Sebti et al. [23, 24]. The synthesized 
chalcones on treatment with phenylhydrazine 
hydrochloride via clay catalysis afforded isomeric 1, 3, 
5-triaryl-2-pyrazoline derivatives (4a-n) (Scheme 1). 
 
            
Scheme 1: Synthesis of 1,3,5-triaryl-2-pyrazolines.  
 
For the said transformations, both conventional as well 
as non-conventional clay catalyzed microwave 
irradiation approaches have been explored and results 
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Table 1. Comparison of reaction time and yields of products (3a-n and 4a-n) under microwave and conventional 
method. 
 
Compd. Reaction time yield/ % Compd Reaction time yield/ % 
MW/min Conventional/h MW Conventional  MW/min Conventional/h MW Conventional 
3a 6 24 73 66 4a 5.5 9 74 65 
3b 5 24 68 62 4b 5.5 8 79 68 
3c 7 24 70 65 4c 6 10 78 65 
3d 8 22 72 66 4d 6 10 80 67 
3e 5 24 72 67 4e 6.5 9 76 61 
3f 6 22 80 68 4f 7.5 8 77 63 
3g 7 26 69 62 4g 6.5 11 79 65 
3h 8 26 72 61 4h 6 10.5 80 67 
3i 8 24 71 65 4i 8.0 10.5 82 65 
3j 7 23 70 66 4j 5.5 10 83 66 
3k 8 23 77 64 4k 7.5 11 84 68 
3l 6 25 75 62 4l 6.0 10.5 80 67 
3m 7 23 72 66 4m 7.0 11 82 67 
3n 8 25 73 65 4n 8.0 12 79 65 
 
 
In view of the immense utility of eco-friendly 
synthetic approaches, improved syntheses of 
pyrazolines were performed using different inorganic 
solid supports as heterogeneous catalysts under 
microwave irradiation. In this context, the suitability of 
different inorganic solid supports i.e., acidic alumina, 
basic alumina, neutral alumina, montmorillonite K-10 
and K2CO3 were examined in presence of microwave 
irradiation. According to (Table 2), the observed 
percentage yield of the products obtained with 
montmorrilonite K-10 clay as inorganic solid support 
is best than other solid supports and neat (without 
catalysts). This observation can be attributed to the 
more surface area and catalytic character in 
montmorrilonite K-10 than that of the other inorganic 
solids. Also, the clay possesses some advance 
properties like cation exchange capacity and swelling 
ability, thereby accommodating various guest species 
in its interlayers. An attempt has also been made to 
carried out the said transformation with different 
inorganic solid supports in the absentia of MW 
irradiation with conventional protocol resulted very 
poor yields (40-50%) confirms the MW irradiation as 
one of the best available energy sources. 
 
Table 2. Different inorganic solid supports in non-conventional MW irradiated synthesis of (4a–n). 
 
Exp. No. Solid supports MW Power, W Time, min Temp., °C Yield,  % 
1. Alumina acidic 700 9.0-10.0 73 59 
2. Alumina basic 700 11.0-12.0 79 70 
3. Alumina neutral 700 10.0-11.0 76 64 
4. Montmorillonite K 
10 
700 7.0-8.0 89 80 
5. K2CO3 700 12.5–13.5 72 65 
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The products were identified by their spectral data, 
physical data (melting point, elemental analysis), and 
comparison with authentic ones FTIR spectra 
supported the above observation, a peak observed 
around at 1672-1695 (C=O stretching), 1631-1634 (-
CH=CH stretching); 1H NMR spectrum revealed the 
presence of a doublet at δ 7.49-7.62 corresponding to α 
hydrogen  and doublet at δ 7.78-7.88 corresponding to 
for β hydrogen respectively (3a-n) and  the structures 
of the newly synthesized compounds (4a-n) showed 
FTIR spectrum bands at 1570-1594 (C=C stretching), 
1625-1650 (C=N stretching); 1H NMR spectrum 
revealed the presence of a two double doublet at δ 
3.01-3.28 and  δ 3.49-3.78 corresponding to two 
hydrogen of -CH2 of 2-pyrazolines and double doublet 
at δ 5.42- 5.88 corresponding to –CH- of 2-
Pyrazolines.  
Reusability is one of the important properties of this 
catalyst. In this study, due to the fact that the catalyst 
was insoluble in dichloromethane, it could therefore be 
recycled by a simple filtration. The separated catalyst 
was washed with dichloromethane, dried at 60°C under 
vacuum for 30 min. and reused in another reaction. 
The results show that there is no any significant 
loss of activity in using recycled catalyst after three 




Figure 1. Recyclability of montmorrilonite clay K10 
 
Antimicrobial evaluation: 
All the newly synthesized pyrazolines (4a-n) were 
screened for their antimicrobial evaluation using 
chloramphenicol and fluconazole as positive controls. 
Table 3 shows that all the newly synthesized 
compounds (4a-n) were able to inhibit bacterial and 
fungal growth and create a zone of inhibition.  
 
Table 3. Animicrobial activity of 1, 3, 5-triaryl-2-pyrazoline derivatives (4a-n) 
Compounds 
 
Zone of inhibition Zone of inhibition 
B. pumilis E. coli A. niger P.crysogenum 
0.05mL 0.1mL 0.05mL 0.1mL 0.05mL 0.1mL 0.05mL 0.1mL 
4a 8 10 10 11 12 13 10 13 
4b 10 13 11 12 15 18 15 17 
4c 10 11 9 11 13 14 12 14 
4d 9 10 9 10 12 14 13 15 
4e 10 12 8 10 15 17 14 15 
4f 9 11 8 10 13 15 9 11 
4g 13 16 9 12 10 13 8 12 
4h 12 13 11 13 9 11 9 13 
4i 12 13 12 14 8 10 10 13 
4j 14 16 12 13 9 10 11 14 
4k 11 15 11 13 10 11 9 12 
4l 13 14 10 12 10 11 12 15 
4m 14 13 9 12 12 13 16 18 
4n 13 14 8 11 11 13 12 14 
Chloramphenicol 15 17 15 13 - - - - 
Fluconazole - - - - 15 16 15 17 
 
 
The results revealed a significant inhibitory activity 
of all compounds against both fungal and bacterial 
strains. Aspergillus fungal strain shows higher 
susceptibility towards pyrazoline derivatives: (4b) and 
(4e) while growth of Penicilium fungal strain was 
maximum inhibited by (4m). Growth of both bacterial 
strains Bacillus and Escherichia was inhibited 
maximum by (4j). The control plate did not exhibit 
inhibition on the tested fungi and bacteria where as 
positive controls Fluconazole and Chloramphenicol 
have antifungal and antibacterial activity even at 
5µg/well respectively. The findings indicate that the 
newly synthesized pyrazoline derivatives can be used 
Iranian Journal of Organic Chemistry Vol. 8, No. 3 (2016) 1833-1844                                                             K. L. Ameta et al. 
1837 
 
as potent biocide as they showed maximum zone of 
inhibition nearly equal to the standard antifungal and 
antibacterial  
Experimental Section 
All melting points (m.ps.) were determined in open 
capillaries on Veego (VMP-PM) melting point 
apparatus and were uncorrected. The purity of the 
compounds was routinely checked by mixed mps and 
thin layer chromatography (TLC) with Silica Gel-G 
(Merck) plates using benzene: ethyl acetate (9:1 v/v) as 
eluent. The instruments used for spectroscopic data 
are; IR spectra was recorded in KBr on a Perkin-Elmer 
spectrophotometer model RX I (υmax in cm-1), 1H NMR 
(CDCl3) on 500 MHz and 13C NMR (CDCl3) on 125 
MHz FT-NMR spectrometer Bruker AV III with 
tetramethylsilane (TMS) as an internal standard, Mass 
spectral analysis performed on JEOL GC mate and 
elemental analysis was carried out on a Carlo Erba 
1108 analyzer and were within the ± 0.5 % of the 
theoretical values. Microwave assisted reactions were 
carried out on a MW synthesizer model CATA-R, 
operating 700W, generating 2450 MHz frequency. The 
compounds were evaluated for antibacterial activity 
against Bacillus pumilus and Escherichia coli and 
antifungal activity against Aspergillus niger and 
Penicillium crysogenum.  
General procedures for the synthesis of chalcones 
(3a-n): 
  
 Both conventional as well as non-conventional 
protocols have been explored to synthesize compounds 
(3a-n) and (4a-n) and find the non-conventional 
montmorrilonite K10 catalyzed microwave assisted 
method as a better one with improved yield and shorter 
reaction time.  
  
Solution phase conventional method: 
A mixture of 4-nitroacetophenone 1 (1.65 g, 0.01 
mol) and substituted aromatic aldehyde 2a (1.02 ml, 0. 
01 mol) was stirred in ethanol (30 mL) followed by the 
drop wise addition of aqueous solution of KOH (40%, 
15 mL). The resulted reaction mixture was kept 
overnight at room temperature and then it was poured 
into crushed ice and acidified with dil. HCl. The solid 
separated was filtered off and recrystallized from 
ethanol afforded analytical samples of (3a-n). 
Solid phase non-conventional method 
To a solution of 4-nitroacetophenone 1 (1.65 g, 0.01 
mol) and substituted aromatic aldehyde 2a (1.02 ml, 0. 
01 mol) in DMF (1 mL) was taken in a 100 mL borosil 
flask, to this, montmorrilonite K10 (4g) was added and 
uniformly mixed with glass rod. The resulted slurry 
was air dried to become powder form by removing the 
solvent. Adsorbed powder was irradiated inside a 
microwave synthesizer for 5-8 min. at the medium 
power level (700 W). After the completion of the 
reaction (monitored by TLC), the reaction mixture was 
cooled at room temperature, and the product was 
extracted with dichloromethane (2 x 20 mL). Removal 
of the solvent and subsequent recrystallization with 
ethanol resulted analytical samples of (3a-n).  
 
























Light red solid; m.p. 159-160°C; IR (KBr, cm-1): 1360 
(Ar-NO2), 1632 (-CH=CH str.), 1693 (-C=O str.), 3432 
(O-H str.); 13C NMR (100 MHz, CDCl3): δ 121.2(C2), 
145.6(C3), 189.4(C1), 122.4(C3'/5'), 129.6(C2'/6'), 
141.4(C1'), 150.2(C4'), 127.9(C4''), 128.2(C2''/ C6''), 
131.3(C3''/C5''), 133.4(C1''); 1H NMR (500 MHz, 
CDCl3): δ 7.00-7.42 (m, 4H, ArH), 7.50 (d, αH, 
J=15.3Hz), 7.80 (d, βH, J=15.3Hz), 7.82-8.10 (m, 5H, 
ArH); MS: (m/z): 253.00 [M+]. Anal.Calcd.for 
C15H11O3N: C, 71.15; H, 4.35; N, 5.53 %. Found: C, 
71.45; H, 4.10; N, 5.90%. 
  
(2E)-3-(2-chlorophenyl)-1-(4-nitrophenyl)prop-2-en-1-
one(3b): Light yellow solid; m.p. 167-168°C; IR (KBr, 
cm-1): 825 (C-Cl str.), 1355 (Ar-NO2), 1615 (-CH=CH 
str.), 1672 (-C=O str.), 3434 (O-H str.); 13C-NMR (100 
MHz, CDCl3): δ124.2(C2), 136.4(C3), 191.2(C1), 
121.3(C3'/5'), 128.7(C2'/6'), 142.2(C1'), 
151.4(C4'),126.1(C4''), 128.7(C2''/ C6''), 
130.1(C3''/C5''), 132.3(C1''), 132.4(C4''), 132.8(C2'');  
1H-NMR (500 MHz, CDCl3): δ  7.08-7.50 (m, 4H, 
ArH), 7.60 (d, αH, J=15.3Hz), 7.85 (d, βH, J=15.3Hz), 
7.87-8.12 (m, 4H, ArH); MS: m/z) 287.50 [M+]. 
Anal.Calcd.for C15H10O3NCl: C, 62.61; H, 3.48; N, 
4.87 %. Found: C, 62.30; H, 3.78; N, 4.50%. 





one (3c): Dark yellow solid; m.p. 130-131°C; IR (KBr, 
cm-1): 815 (C-Cl str.), 1355 (Ar-NO2), 1632 (-CH=CH 
str.), 1692 (-C=O str.), 3429 (O-H str.); 13C-NMR (100 
MHz, CDCl3): δ 123.6(C2), 141.3(C3), 190.4(C1), 
122.8(C3'/C5'), 128.6(C2'/C6'), 141.5(C1'), 149.9(C4'), 
127.4(C6''), 128.4(C2''/C4''), 131.8(C5''), 133.7(C1''), 
135.4(C3'');  1H-NMR (500 MHz, CDCl3): δ 7.02-7.48 
(m, 4H, ArH), 7.62 (d, αH, J=15.3Hz), 7.83 (d, βH, 
J=15.3Hz), 7.86-8.10 (m, 4H, ArH); MS: (m/z) 287.50 
[M+]. Anal.Calcdfor C15H10O3NCl: C, 62.61; H, 3.48; 
N, 4.87 %. Found: C, 62.89; H, 3.23; N, 5.20%. 
 
(2E)-3-(4-chlorophenyl)-1-(4-nitrophenyl)prop-2-en-1-
one(3d): Orange solid; m.p. 159-160°C; IR (KBr, cm-
1): 818 (C-Cl str.), 1358 (Ar -NO2), 1634 (-CH=CH 
str.), 1693 (-C=O str.), 3432 (O-H str.); 13C-NMR (100 
MHz, CDCl3): δ 119.9(C2), 141.6(C3), 188.8(C1), 
121.2(C3'/C5'), 129.3(C2'/C6'), 142.7(C1'), 
150.6(C4'),128.6(C3''/C5''), 130.1(C2''/C6''), 
131.2(C1''), 138.(C4''); 1H-NMR (500 MHz, CDCl3): δ 
7.05-7.48 (m, 4H, ArH), 7.61 (d, αH, J=15.3Hz), 7.81 
(d, βH, J=15.3Hz), 7.86-8.10 (m, 4H, ArH); MS: (m/z) 
287.50 [M+]. Anal.Calcd.for C15H10O3NCl: C, 62.61; 




en-1-one(3e):Dark yellow solid; m.p. 151-152°C; IR 
(KBr, cm-1): 816 (C-Cl str.), 1360 (Ar-NO2), 1631 (-
CH=CH str.), 1692 (-C=O str.), 3435 (O-H str.) ; 13C-
NMR (100 MHz, CDCl3):  δ123.7(C2), 136.6(C3), 
189.7(C1), 122.5(C3'/C5'), 128.7(C2'/C6'), 142.5(C1'), 
151.4(C4'), 127.4(C5''),  127.9(C3''), 128.7(C4''), 
130.4(C6''), 130.7(C1''), 135.3(C2'');  1H-NMR (500 
MHz, CDCl3): δ 7.08-7.43 (m, 4H, ArH), 7.52 (d, αH, 
J=15.3Hz), 7.80 (d, βH, J=15.3Hz), 7.82-8.10 (m, 3H, 
ArH); MS: (m/z) 322.00 [M+]. Anal.Calcd.for 
C15H9O3NCl2: C, 55.90; H, 2.79; N, 4.35 %. Found: C, 
55.53; H, 2.45; N, 4.65%.   
 
(2E)-3-(4-bromophenyl)-1-(4-nitrophenyl)prop-2-en-1-
one(3f):Yellow solid; m.p. 155-156°C; IR (KBr, cm-1): 
748 (C-Br), 1362 (Ar-NO2),  1633 (-CH=CH str.), 
1693 (-C=O str.), 3429 (O-H str.); 13C-NMR (100 
MHz, CDCl3):  δ118.9(C2), 141.8(C3), 187.6(C1), 
121.2(C3'/C5'), 129.2(C2'/C6'), 141.8(C1'), 150.3(C4'), 
123.8(C4''), 129.9(C2''/C6''), 130.2(C3''/C5''), 
131.2(C1'');  1H-NMR (500 MHz, CDCl3) δ 6.95-7.35 
(m, 4H, ArH), 7.49 (d, αH, J=15.3Hz), 7.78 (d, βH, 
J=15.3Hz), 7.82-8.08 (m, 4H, ArH); MS: (m/z) 331.90 
[M+]. Anal.Calcd.for C15H10O3NBr: C, 54.23; H, 3.01; 
N, 4.22 %. Found: C, 54.43; H, 3.30; N, 3.89%. 
 
 (2E)-3-(4-fluorophenyl)-1-(4-nitrophenyl)prop-2-en-
1-one(3g):Red solid; m.p. 146-147°C; IR (KBr, cm-1): 
1156 (C-F), 1362 (Ar-NO2), 1633 (-CH=CH str.), 1693 
(-C=O str.), 3429 (O-H str.); 13C-NMR (100 MHz, 
CDCl3):  δ121.5(C2), 142.2(C3), 191.5(C1), 
122.8(C3'/C5'), 128.6(C2'/C6'), 142.2(C1'), 151.8(C4'), 
115.1(C3''/C5''), 130.2(C1''), 130.6(C2''/C6''), 
162.4(C4'');  1H-NMR (500 MHz, CDCl3): δ 7.02-7.48 
(m, 4H, ArH), 7.53 (d, αH, J=15.3Hz), 7.79 (d, βH, 
J=15.3Hz), 7.82-8.06 (m, 4H, ArH); MS: (m/z) 271.00 
[M+]. Anal.Calcd.for C15H10O3NF: C, 66.42; H, 3.69; 
N, 5.16 %. Found: C, 66.20; H, 3.94; N, 5.47%. 
 
(2E)-3-(3-nitrophenyl)-1-(4-nitrophenyl)prop-2-en-1-
one(3h):Light yellow solid; m.p. 171-172°C; IR (KBr, 
cm-1): 1360, 1505 (Ar-NO2), 1632 (-CH=CH str.), 
1699 (-C=O str.), 3431 (O-H str.) ; 13C-NMR (100 
MHz, CDCl3): δ124.1(C2), 141.3(C3), 188.3(C1), 
121.7(C3'/C5'), 129.3(C2'/C6'), 141.4(C1'), 150.8(C4'), 
121.4(C4''), 123.4(C2''), 129.1(C5''),  135.7(C6''), 
136.5(C1''), 150.5(C3'');  1H-NMR (500 MHz, CDCl3): 
δ 6.96-7.40 (m, 4H, ArH), 7.55 (d, αH, J=15.3Hz), 
7.80 (d, βH, J=15.3Hz), 7.88-8.05 (m, 4H, ArH); MS: 
(m/z) 250.00 [M+]. Anal.Calcd.for C15H10O5N2: C, 




one(3i):Dark Red solid; m.p. 208-209°C; IR (KBr, cm-
1): 1359 (Ar-NO2), 1631 (-CH=CH str.), 1691 (-C=O 
str.), 2913 (aliphatic C-H str.),  3433 (O-H str.); 13C-
NMR (100 MHz, CDCl3): δ121.3(C2), 143.8(C3), 
189.4(C1), 122.7 (C3'/C5'), 129.7(C2'/C6'), 142.8(C1'), 
151.5(C4'), 129.2(C2''/C6''), 130.6(C3''/C5''), 
131.2(C1''), 138.6(C4'');  1H-NMR (500 MHz, CDCl3): 
δ  2.63 (3H, s, -CH3), 6.92-7.42 (m, 4H, ArH), 7.51 (d, 
αH, J=15.3Hz), 7.82 (d, βH, J=15.3Hz), 7.83-8.02 (m, 
4H, ArH); MS: (m/z) 267.00 [M+]. Anal.Calcd.for 
C16H13O3N: C, 71.91; H, 4.87; N, 5.24 %. Found: C, 
71.70; H, 4.40; N, 5.59%. 
 
(2E)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)prop-2-en-
1-one(3j): Orange solid; m.p. 149-150°C; IR (KBr, cm-
1): 1355 (Ar-NO2), 1631 (-CH=CH str.), 1693 (-C=O 
str.), 2820 (OCH3), 3435 (O-H str.); 13C-NMR (100 
MHz, CDCl3): δ119.9(C2), 143.7(C3), 191.3(C1), 
121.4(C3'/C5'), 128.9(C2'/C6'), 141.9(C1'), 150.6(C4'), 
116.1(C3''/C5''), 126.3(C1''), 130.7(C2''/C6''), 
162.6(C4''), OMe(55.4);  1H-NMR (500 MHz, CDCl3): 
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δ  3.87 (s, 3H, OCH3), 6.98-7.52 (m, 4H, ArH), 7.57 
(d, αH, J=15.3Hz), 7.80 (d, βH, J=15.3Hz), 7.83-7.98 
(m, 4H, ArH); MS: (m/z) 283.00 [M+]. Anal.Calcd.for 
C16H13O4N: C, 67.84; H, 4.59; N, 4.95 %. Found: C, 
68.10; H, 4.89; N, 4.70%. 
 
(2E)-3-(3,4-dimethoxyphenyl)-1-(4-nitrophenyl)prop-
2-en-1-one(3k):Orange solid; m.p. 182-183°C; IR 
(KBr, cm-1): 1358 (Ar-NO2), 1633 (-CH=CH str.), 
1695 (-C=O str.), 2815 (OCH3), 3435 (O-H str.); 13C-
NMR (100 MHz, CDCl3):  δ121.8(C2), 143.9(C3), 
190.1(C1), 122.4(C3'/C5'), 129.4(C2'/C6'), 142.4(C1'), 
152.2(C4'), 112.1(C5''), 113.8(C2''), 120.8(C6''), 
127.8(C1''), 150.2(C4''), 151.2(C3''), OMe (56.6, 59.7);  
1H-NMR (500 MHz, CDCl3): δ 3.95 (s, 6H, 2 x 
OCH3), 6.93-7.42 (m, 4H, ArH), 7.54 (d, αH, 
J=15.3Hz), 7.85 (d, βH, J=15.3Hz), 7.88-8.16 (m, 3H, 
ArH); MS: (m/z) 313.00 [M+]. Anal.Calcd.for 
C17H15O5N: C, 65.17; H, 4.79; N, 4.47 %. Found: C, 
65.37; H, 4.55; N, 4.69%. 
 
(2E)-3-(3,4,5-trimethoxyphenyl)-1-(4-nitrophenyl) 
prop-2-en-1-one(3l):Dark red solid; m.p. 153-154°C; 
IR (KBr, cm-1): 1360 (Ar-NO2), 1631 (-CH=CH str.), 
1692 (-C=O str.), 2825 (OCH3), 3438 (O-H str.); 13C-
NMR (100 MHz, CDCl3): δ122.5(C2), 142.8(C3), 
188.5(C1), 121.5(C3'/C5'), 128.9(C2'/C6'), 141.1(C1'), 
151.6(C4'), 105.5(C2''/C6''), 130.5(C1''), 140.3(C4''), 
154.7(C3''/C5''), OMe (56.7, 60.3);  1H-NMR (500 
MHz, CDCl3): δ 3.97 (s, 9H, 3 x OCH3), 6.95-7.49 (m, 
4H, ArH), 7.53 (d, αH, J=15.3Hz), 7.82 (d, βH, 
J=15.3Hz), 7.85-8.12 (m, 2H, ArH); MS: (m/z) 343.00 
[M+]. Anal.Calcd.for C18H17O6N: C, 62.97; H, 4.96; N, 
4.08 %. Found: C, 62.72; H, 4.70; N, 4.23%. 
 
(2E)-3-(3-hydroxy-4-methoxyphenyl)-1-(4-
nitrophenyl)prop-2-en-1-one(3m): Dark yellow solid; 
m.p. 158-159°C; IR (KBr, cm-1): 1357 (Ar-NO2), 1632 
(-CH=CH str.), 1693 (-C=O str.),  2827 (OCH3), 3440 
(O-H str.); 13C-NMR (100 MHz, CDCl3): δ123.9(C2), 
143.1(C3), 189.3(C1), 122.2(C3'/C5'), 129.4(C2'/C6'), 
142.6(C1'), 150.2(C4'), 110.8(C5''), 113.8(C2''), 
120.6(C6''), 127.2(C1''), 145.7(C3''), 153.4(C4''), OMe 
(55.9, 61.2);  1H-NMR (500 MHz, CDCl3): δ  3.93 (s, 
3H, OCH3), 6.99-7.50 (m, 4H, ArH), 7.55 (d, αH, 
J=15.3Hz), 7.88 (d, βH, J=15.3Hz), 7.95-8.15 (m, 3H, 
ArH), 11.92 (s, 1H, Ar-OH); MS: (m/z) 303.00 [M+]. 
Anal.Calcd.for C16H13O5N: C, 63.37; H, 4.29; N, 4.62 
%. Found: C, 63.64; H, 4.03; N, 4.93%. 
 
(2E)-3-(3-bromo-4-hydroxy-5-methoxyphenyl)-1-(4-
nitrophenyl)prop-2-en-1-one(3n): Orange solid; m.p. 
143-144°C; IR (KBr, cm-1): 737 (C-Br), 1360 (Ar-
NO2), 1631 (-CH=CH str.), 1694 (-C=O str.), 2823 
(OCH3), 3435 (O-H str.); 13C-NMR (100 MHz, 
CDCl3): δ122.3(C2), 142.9(C3), 190.4(C1), 
121.3(C3'/C5'), 128.3(C2'/C6'', 141.4(C1'), 149.5(C4'), 
108.8(C2''), 111.8(C5''), 130.6(C1''), 133.7(C6''), 
149.3(C3''), 151.6(C4''), OMe (56.6);  1H-NMR (500 
MHz, CDCl3): δ 3.94 (s, 3H, OCH3), 6.92-7.38 (m, 4H, 
ArH), 7.53 (d, αH, J=15.3Hz), 7.85 (d, βH, J=15.3Hz), 
7.92-8.11 (m, 2H, ArH), 11.97 (s, 1H, Ar-OH); MS: 
(m/z) 381.90 [M+]. Anal.Calcd.for C16H12O5NBr: C, 
50.27; H, 3.14; N, 3.66 %. Found: C, 50.56; H, 2.95; 
N, 3.91%. 
  
General procedure for the synthesis of 1, 3, 5-
triaryl-2-pyrazolines (4a-n) 
 
Solution phase conventional method: 
A solution of substituted chalcones 3a-n (1.265 g, 
0.005 mol) and phenylhydrazine hydrochloride (0.72 g, 
0.015 mol) in glacial acetic acid (30 mL) was refluxed 
for about 10-12 hrs. Excess of solvent was removed 
under reduced pressure, and the reaction mixture was 
poured into ice-cold water. The product obtained was, 
filtered, washed with water and recrystallized from 
ethanol resulted analytical samples of (4a-n).  
 
Solid phase non-conventional method 
To a solution of substituted chalcones 3a (1.265 g, 
0.005 mol) and phenylhydrazine hydrochloride (0.72 g, 
0.015 mol) in DMF (1 mL) taken in a 100 mL borosil 
flask, to this montmorrilonite K10 (4gm) was added. 
The resulted slurry was air dried to become powder 
form by removing the solvent. Adsorbed powder was 
irradiated inside a microwave synthesizer for 5-8 min. 
at the medium power level (700 W). After the 
completion of the reaction (monitored by TLC), the 
reaction mixture was cooled at room temperature, and 
the product was extracted with ethanol (2 x 20 mL). 
Removal of the solvent and subsequent 
recrystallization with ethanol resulted analytical 
samples of isomeric mixture 1, 3, 5-triaryl-2-
pyrazoline derivatives (4a-n). Comparison of reaction 
time and yields of the products under microwave and 
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pyrazole (4a): Orange solid, m.p. 165-166°C; IR (KBr, 
cm-1): 1363 (Ar-NO2), 1590 (C=C str.), 1645 (C=N 
str.), 2921 (aliphatic C-H str.), 3009, 3067 (Ar- CH 
str.),  3399 (O-H str.); 13C NMR (100 MHz, CDCl3): δ: 
43.1(C4), 68.7(C5), 149.8(C3), 112.4(C7/C11), 
118.3(C9), 128.4(C8/C10), 146.3(C6), 
122.7(C14/C16), 128.3(C13/17), 140.3(C12), 
146.2(C15), 127.3(C20/C22), 128.1(C19/C23), 
128.5(C21), 144.6(C18); 1H NMR (500 MHz, CDCl3): 
δ 3.01 (1H, dd, J= 15.5Hz, J= 5.5Hz,  CHHA), 3.65 
(1H, dd, J= 15.5Hz, J= 6.1Hz,   CHBH), 5.48 (1H, dd, 
J= 12.6 Hz, J= 5.1Hz,   CHAr), 7.10-7.38 ( 5H, m, 
ArH), 7.48-7.77 (4H, m, ArH), 7.99-8.34 (5H, m, 
ArH); MS: (m/z) 343.00 [M+]. Anal.Calcd.for 
C21H17O2N3: C, 73.47; H, 4.96; N, 12.24 %. Found: C, 
73.67; H, 4.71; N, 12.59%. 
 
5-(2-chlorophenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4b):Light red solid, m.p. 153-
154°C; IR (KBr, cm-1): 753 (C-Cl str.), 1362 (Ar-NO2), 
1584 (C=C stretching),1650 (C=N str.), 2920 (aliphatic 
C-H str.), 3007, 3060 (Ar-CH str.), 3419 (O-H str.); 
13C NMR (100 MHz, CDCl3): δ:44.3(C4), 67.6(C5), 
148.5(C3), 113.6(C7/C11), 117.4(C9), 128.6(C8/C10), 
145.8(C6), 121.3(C14/C16), 129.5(C13/C17), 
139.6(C12), 147.2(C15), 126.3(C23), 127.7(C20), 
128.2(C21), 128.7(C22), 134.2(C19), 138.3(C18);   1H 
NMR (500 MHz, CDCl3): δ 3.10 (1H, dd, J= 15.8Hz, 
J= 6.5Hz,   CHHA ), 3.58 (1H, dd, J= 15.8Hz, J= 
5.9Hz,   CHBH ), 5.42 (1H, dd, J= 12.5Hz, J= 6.1Hz,  
CHAr),  7.08-7.42 ( 5H, m, ArH),  7.58-7.72 (4H, m, 
ArH), 7.89-8.24 (4H, m, ArH); MS: (m/z) 377.50 [M+]. 
Anal.Calcd.for C21H16O2N3Cl: C, 66.75; H, 4.24; N, 
11.12 %. Found: C, 66.97; H, 4.04; N, 11.52%. 
 
5-(3-chlorophenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4c): Red solid, m.p. 142-143°C; 
IR (KBr, cm-1): 760 (C-Cl str.),  1580 (C=C str.), 1638 
(C=N str.), 2931 (aliphatic C-H str.), 3011, 3067 (Ar-
CH str.), 3423 (O-H str.); 13C NMR (100 MHz, 
CDCl3): δ 44.8(C4), 66.4(C5), 150.7(C3), 
113.1(C7/C11), 117.3(C9), 127.2(C8/C10), 
146.1(C6),123.8(C14/C16), 128.6(C13/17), 
139.4(C12), 146.5(C15), 124.6(C23), 126.4(C19), 
127.8(C21), 133.6(C22), 137.6(C20), 138.7(C18);  1H 
NMR (500 MHz, CDCl3): δ 3.02 (1H, dd, J= 15.5Hz, 
J= 6.7Hz,   CHHA), 3.58 (1H, dd, J= 15.5Hz, J= 
6.1Hz,   CHBH), 5.52 (1H, dd, J= 12.6Hz, J= 6.3Hz, 
CHAr), 7.05-7.39 ( 5H, m, ArH)), 7.42-7.78 (4H, m, 
ArH)), 7.82-8.12 (4H, m, ArH)); MS: (m/z) 377.50 
[M+]. Anal.Calcd.for C21H16O2N3Cl: C,66.75; H, 4.24; 
N, 11.12 %. Found: C, 66.96; H, 4.01; N, 11.37%.   
5-(4-chlorophenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4d):Red solid, m.p. 139-140°C; 
IR (KBr, cm-1): 752 (C-Cl str.), 1355 (Ar-NO2), 1575 
(C=C str.), 1640 (C=N str.), 2922 (aliphatic C-H str.), 
3011, 3067 (Ar-CH str.), 3422 (O-H str.); 13C NMR 
(100 MHz, CDCl3): δ 43.3(C4), 67.1(C5), 149.2(C3), 
112.2(C7/C11), 118.7(C9), 128.5(C8/C10), 145.5(C6), 
122.2(C14/C16), 128.2(C13/C17), 140.3(C12), 147.7 
(C15),128.5(C19/C23), 130.2 (C20/C22), 134.9(C21), 
140.2(C18);  1H NMR (500 MHz, CDCl3): δ 3.20 (1H, 
dd, J= 15.6Hz, J= 7.1Hz,   CHHA), 3.52 (1H, dd, J= 
15.6Hz, J= 7.4Hz,    CHBH), 5.58 (1H, dd, J= 12.5, J= 
6.9Hz,   ArCH), 7.22-7.33 ( 5H, m, ArH), 7.42-7.68 
(4H, m, ArH), 7.88-8.06 (4H, m, ArH); MS: (m/z) 
377.50  [M+]. Anal.Calcd.for C21H16O2N3Cl: C,66.75; 
H, 4.24; N, 11.12 %. Found: C, 66.96; H, 4.59; N, 
10.90%.    
 
5-(2,4-chlorophenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4e): Orange solid; m.p. 183-
184°C; IR (KBr, cm-1): 758, 820 (C-Cl str.), 1362 (Ar-
NO2), 1580 (C=C str.), 1635 (C=N str.), 2935 
(aliphatic C-H str.),  3009, 3069 (Ar- CH str.), 3419 
(O-H str.); 13C NMR (100 MHz, CDCl3): δ 44.1(C4), 
64.8(C5), 148.4(C3), 113.6(C7/C11), 116.4(C9), 
127.2(C8/C10), 147.2(C6), 123.3(C14/16), 
129.4(C13/C17), 140.8(C12), 148.3(C15), 126.3(C22), 
129.5(C20), 130.4(C21), 133.1(C23), 133.8(C19), 
136.7(C18);  1H NMR (500 MHz, CDCl3, δ / ppm): 
3.08 (1H, dd, J= 15.7Hz, J= 7.2Hz,   CHHA), 3.62 (1H, 
dd, J= 15.7Hz, J= 7.7Hz,   CHBH), 5.52 (1H, dd, J= 
12.6, J= 7.1Hz,   CHAr), 7.12-7.38 ( 5H, m, ArH), 
7.42-7.72 (4H, m, ArH), 7.82-7.96 (3H, m, ArH); MS: 
(m/z) 412.00 [M+]. Anal.Calcd.for C21H15O2N3Cl2: 
C,61.16; H, 3.64; N, 10.19 %. Found: C, 61.40; H, 
3.89; N, 9.90%. 
 




dihydro-1H-pyrazole(4f):Dark red solid; m.p. 107-
108°C; IR (KBr, cm-1): 862 (C-Br), 1359 (Ar-NO2), 
1580 (C=C str.), 1628 (C=N str.), 2920 (aliphatic C-H 
str.), 3011, 3068 (Ar-CH str.), 3411 (O-H str.); 13C 
NMR (100 MHz, CDCl3):  δ43.8(C4), 66.3(C5), 
147.1(C3),113.2(C7/C11), 118.8(C9), 127.8(C8/C10), 
146.5(C6),121.4(C14/C16), 129.1(C13/C17), 
139.5(C12), 147.5(C15),123.4(C21), 130.6(C19/C23), 
134.9(C20/C22), 141.8(C18);  1H NMR (500 MHz, 
CDCl3): δ 3.20 (1H, dd, J= 15.8Hz, J= 7.2Hz,   
CHHA), 3.78 (1H, dd, J= 15.8Hz, J= 7.5Hz,   CHBH), 
5.42 (1H, dd, J= 12.5, J= 7.4Hz,   CHAr), 7.12-7.35 ( 
5H, m, ArH), 7.42-7.69 (4H, m, ArH), 7.78-7.98 (4H, 
m, ArH); MS: (m/z) 421.90 [M+]. Anal.Calcd.for 
C21H16O2N3Br: C,59.73; H, 3.79; N, 9.95 %. Found: C, 
59.96; H, 3.53; N, 9.70%. 
 
5-(4-fluorophenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4g): Red solid; m.p. 174-175°C; 
IR (KBr, cm-1): 1244 (C- F), 1362 (Ar-NO2), 1575 
(C=C str.), 1625 (C=N str.), 2920 (aliphatic C-H str.), 
3011, 3051 (Ar-CH str.), 3418 (O-H str.); 13C NMR 
(100 MHz, CDCl3): δ43.3(C4), 67.1(C5), 150.8(C3), 
112.9(C17/C11), 117.3(C9), 128.8(C8/C10), 
46.8(C6),122.5(C14/C16), 129.2(C13/C17), 139.8 
(C12), 147.4 (C15),117.3 (C20/C22), 127.3(C19/C23), 
137.8(C18), 158.3(C21); 1H NMR (500 MHz, CDCl3): 
δ 3.24 (1H, dd, J= 16.0Hz, J= 7.7Hz,   CHHA ), 3.76 
(1H, dd, J= 16.0Hz, J= 7.9Hz,   CHBH), 5.54 (1H, dd, 
J= 12.7, J= 7.1Hz,   CHAr), 7.03-7.28 ( 5H, m, ArH), 
7.51-7.68 (4H, m, ArH), 7.83-8.24 (4H, m, ArH); MS: 
(m/z) 316.00 [M+]. Anal.Calcd.for C21H16O2N3F: 
C,79.75; H, 5.06; N, 13.30 %. Found: C, 79.40; H, 
5.31; N, 13.55%. 
5-(3-nitrophenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4h): Brown solid; m.p. 97-98°C; 
IR (KBr, cm-1): 1366 (Ar-NO2), 1575 (C=C str.), 1628 
(C=N str.), 2931 (aliphatic C-H str.), 3009, 3069 (Ar-
CH str.),  3421 (O-H str.); 13C NMR (100 MHz, 
CDCl3): δ: 44.3(C4), 65.3(C5), 149.3(C3), 
112.7(C7/C11), 117.3(C9), 127.9(C8/C10), 145.7(C6), 
123.2(C14/16), 129.4(C13/C17), 140.4(C12), 
146.8(C15),123.6(C23), 125.2(C21), 129.3(C20), 
132.7(C19), 139.7(18), 151.3(C22);  1H NMR (500 
MHz, CDCl3): δ 3.15 (1H, dd, J= 15.7Hz, J= 7.2Hz,   
CHHA), 3.64 (1H, dd, J= 15.7Hz, J= 7.5Hz,   CHBH), 
5.56 (1H, dd, J= 12.8, J= 7.0Hz,   CHAr), 7.10-7.34 ( 
5H, m, ArH), 7.48-7.72 (4H, m, ArH), 7.88-8.15 (4H, 
m, ArH); MS: (m/z) 388.00 [M+]. Anal.Calcd.for 
C21H16O4N4: C,64.95; H, 4.12; N, 14.43 %. Found: C, 
64.71; H, 4.37; N, 14.10%. 
5-(4-methylphenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4i):Red solid; m.p. 140-141°C; 
IR (KBr, cm-1): 1350 (aromatic-NO2), 1580 (C=C str.), 
1640 (C=N str.), 2930 (aliphatic C-H str.), 3011, 3060 
(Ar-CH str.), 3420 (O-H str.); 13C NMR (100 MHz, 
CDCl3): δ: 43.6(C4), 65.7(C5), 
148.6(C3),113.6(C7/C11), 118.5(C9), 128.3(C8/C10), 
147.8(C6), 123.2(C14/C16), 128.5(C13/C17), 
140.8(C12), 147.2(C15),125.3(C19/C23), 
131.4(C20/C22), 137.7(C21), 139.4(C18);  1H NMR 
(500 MHz, CDCl3): δ 2.91 (3H, s, CH3), 3.22 (1H, dd, 
J= 15.8Hz, J= 4.5Hz,   CHHA), 3.53 (1H, dd, J= 
15.8Hz, J= 4.7Hz,   CHBH), 5.63 (1H, dd, J= 12.8, J= 
4.6Hz,   CHAr),  7.10-7.38 ( 5H, m, ArH), 7.45-7.78 
(4H, m ArH), 7.92-8.21 (4H, m, ArH); MS: (m/z) 
357.00 [M+]. Anal.Calcd.for C22H19O2N3: C,73.95; H, 
5.32; N, 11.76 %. Found: C, 73.71; H, 5.57; N, 
11.99%. 
5-(4-methoxyphenyl)-3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazole(4j): Orange solid; m.p. 176-
177°C; IR (KBr, cm-1): 1358 (Ar-NO2), 1574 (C=C 
str.), 1635 (C=N str.), 2820 (OCH3), 2934 (aliphatic C-
H str.), 3011, 3071 (Ar-CH str.), 3415 (O-H str.); 13C 
NMR (100 MHz, CDCl3): δ44.8(C4), 65.7(C5), 
150.1(C3),112.3( C7/C11), 117.4(C9), 127.5(C8/C10), 
147.9(C6),122.5(C14/C16), 128.3 (C13/C17), 139.6 
(C12), 148.2(C15),116.5(C20/C22), 126.5(C23/C19), 
134.5(C18), 160.3(C21), 55.5(OMe);   1H NMR (500 
MHz, CDCl3): δ 3.16 (1H, dd, J= 15.8Hz, J= 4.5Hz,   
CHHA), 3.67 (1H, dd, J= 15.8Hz, J= 4.7Hz,   CHBH), 
3.97 (3H, s, OCH3), 5.88 (1H, dd, J= 12.7, J= 4.6Hz,   
CHAr), 7.12-7.35 ( 5H, m, ArH), 7.45-7.82 (4H, m, 
ArH), 7.95-8.16 (4H, m, ArH); MS: (m/z) 373.00 [M+]. 
Anal.Calcd.for C22H19O3N3: C,70.78; H, 5.09; N, 11.26 
%. Found: C, 70.43; H, 5.24; N, 11.51%. 
 
5-(3,4-dimethoxyhenyl)-3-(4-nitrophenyl)-1-phenyl-
4,5-dihydro-1H-pyrazole (4k): Orange solid; m.p. 145-
146°C; IR (KBr, cm-1): 1362 (Ar-NO2), 1580 (C=C 
str.), 1640 (C=N str.), 2925 (OCH3), 2931 (aliphatic C-
H str.), 3011, 3067 (Ar-CH str.), 3418 (O-H str.); 13C 
NMR (100 MHz, CDCl3):  δ: 43.2(C4), 66.1(C5), 
149.5(C3), 113.3(C7/C11), 118.5(C9), 128.3(C8/C10), 
146.3(C6), 121.7(C14/C16), 129.3(C13/17), 
140.7(C12), 148.8(C15), 109.6(C19), 113.1(C22), 
121.3(C23), 133.2(C18), 149.1(C21), 151.2(C20), 
55.9(OMe);   1H NMR (500 MHz, CDCl3): δ 3.17 (1H, 
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dd, J= 15.7Hz, J= 4.4Hz,   CHHA), 3.49 (1H, dd, J= 
15.7Hz, J= 4.7Hz,   CHBH), 3.93 (6H, s, 2 x OCH3), 
5.83 (1H, dd, J= 12.8, J= 4.4Hz,   CHAr),  7.06-7.38 ( 
5H, m, ArH), 7.48-7.86 (4H, m, ArH), 7.92-8.11 (3H, 
m, ArH); MS: (m/z) 403.00 [M+]. Anal.Calcd.for 
C23H21O4N3: C,68.49; H, 5.21; N, 10.42 %. Found: C, 
68.71; H, 5.53; N, 10.16%. 
 
5-(3,4,5-trimethoxyhenyl)-3-(4-nitrophenyl)-1-phenyl-
4,5-dihydro-1H-pyrazole(4l): Red solid; m.p. 176-
177°C; IR (KBr, cm-1): 1365 (Ar-NO2), 1583 (C=C 
str.), 1642 (C=N str.), 2929 (OCH3), 2933 (aliphatic C-
H str.), 3011, 3067, (Ar-CH str.), 3420 (O-H str.); 13C 
NMR (100 MHz, CDCl3):  δ: 44.9(C4), 67.6(C5), 
148.4(C3), 112.3(C7/C11), 117.9(C9), 127.1(C8/C10), 
145.2(C6),122.8 (C14/C16), 129.2(C13/C17), 
140.2(C12), 147.3(C15),103.8(C19/C23), 134.7(C18), 
138.3(C21), 155.4(C22), 55.9(OMe);   1H NMR (500 
MHz, CDCl3, δ / ppm): 3.20 (1H, dd, J= 15.8Hz, J= 
4.2Hz,   CHHA), 3.51 (1H, dd, J= 15.8Hz, J= 4.6Hz,   
CHBH), 3.97 (9H, s, 3 x OCH3), 5.80 (1H, dd, J= 12.7, 
J= 4.4Hz,   CHAr), 7.06-7.33 ( 5H, m, ArH), 7.45-7.83 
(4H, m, ArH), 7.95-8.14 (2H, m, ArH); MS: (m/z) 
433.00 [M+]. Anal.Calcd.for C24H23O5N3: C, 66.51; H, 




135°C; IR (KBr, cm-1): 1366 (Ar-NO2), 1590 (C=C 
str.), 1642 (C=N str.), 2915 (OCH3), 2928 (aliphatic C-
H str.), 3009, 3050 (Ar-CH str.), 3422 (O-H str.); 13C 
NMR (100 MHz, CDCl3):  δ43.4(C4), 66.9(C5), 
148.2(C3),113.4(C7/C11), 117.4(C9), 127.8(C8/C10), 
145.6(C6), 123.8(C14/C16), 128.8(C13/C17), 
139.4(C12), 148.2(C15),116.7(C22), 117.6(C19), 
122.3(C23), 133.2(C18), 146.5(C21), 151.5(C20), 56.4 
(OMe);   1H NMR (500 MHz, CDCl3): δ 3.28 (1H, dd, 
J= 15.6Hz, J= 4.1Hz,   CHHA), 3.72 (1H, dd, J= 
15.6Hz, J= 4.4Hz,  CHBH), 3.95 (3H, s, OCH3), 5.46 
(1H, dd, J= 12.5, J= 4.3Hz, CHAr),  7.11-7.40 ( 5H, m, 
ArH), 7.52-7.84 (4H, m, ArH), 7.92-8.15 (3H, m, 
ArH), 10.97 (1H, s, Ar-OH); MS: (m/z) 389.00 [M+]. 
Anal.Calcd.for C22H19O4N3: C, 67.87; H, 4.88; N, 
10.80 %. Found: C, 67.51; H, 4.73; N, 11.05%.   
2-bromo-6-methoxy-4-[3-(4-nitrophenyl)-1-phenyl-4,5-
dihydro-1H-pyrazol-5-yl]phenol (4n): Red solid; mp. 
90-91°C; IR (KBr, cm-1): 862 (C-Br), 1359 (Ar-NO2), 
1593 (C=C str.), 1660 (C=N str.), 2830 (OCH3), 2919 
(aliphatic C-H str.), 3009, 3061 (Ar-CH str.), 3392 (O-
H str.); 13C NMR (100 MHz, CDCl3): δ44.3(C4), 
65.3(C5), 150.1(C3), 113.4(C7/C11), 118.4(C9), 
128.3(C8/C10), 144.8(C6), 123.4(C14/C16), 
129.5(C13/C17), 139.8(C12), 147.1(C15), 111.4(C19), 
117.3(C22), 124.4(C23), 135.3(C18), 147.4(C21), 
149.2(C20), 56.7(OMe);  1H NMR (500 MHz, CDCl3): 
δ 3.20 (1H, dd, J= 15.7Hz, J= 5.2Hz,   CHHA), 3.52 
(1H, dd, J= 15.7Hz, J= 5.5Hz,   CHBH), 5.69 (1H, dd, 
J= 12.6, J= 5.4Hz,   CHAr),  3.89 (3H, s, OCH3), 7.11-
7.49 ( 5H, m, ArH), 7.85-7.94 ((2H, m, ArH), 7.99-
8.34 (4H, m, ArH), 10.80 (1H, s, Ar-OH); MS: (m/z) 
467.90 [M+]. Anal.Calcd.for C22H18O4N3Br: C, 56.42; 




  Antibacterial and antifungal evaluation of newly 
synthesized pyrazoline derivatives were carried out by 
agar well diffusion method and mycelium inhibition 
method [25, 26], respectively with some modifications. 
Each compound (5 mg) was dissolved in 5 mL of 
dimethyl sulfoxide (1000 µg / mL). Volumes of 0.05 
mL and 0.1 mL of each compound were used for the 
antimicrobial evaluation. 
For antibacterial activity tests, 1.0 mLof 24h old 
bacterial broth culture was homogeneously spread on 
solidified agar plates. After 5-10 mm wells were made 
by using gel puncture and filled with 500 µl of test 
compound solution (homogenized using an ultrasonic 
cleaner). The plates were incubated at 37°C for 24h. 
The zone size was determined by measuring the radius 
of the zone of inhibition by scale and divider. 
For antifungal activity, about 15 mL of the 
Potato Dextrose Agar (PDA) medium was poured into 
petri plates and allowed to solidify. After 
solidification, 500 uL of test compound was spread on 
them with the help of sterilized swab.  Five mm disc of 
7-day-old culture of the test fungi was placed at the 
centre of the petri plates and incubated at 25±2 ºC for 
seven days. After incubation the colony diameter was 
measured in millimeter. Dimethyl Sulphoxide was 
used as a control which did not reveal any inhibition. 
Chloramphenicol for antibacterial and fluconazole for 
antifungal were used as the standard drugs. Each 
experiment was carried out in triplicate. 
Statistical calculations 
For statistical analysis, SPSS Statistics 17.0 software 
was used and all tests were performed in triplicate, and 
the results were expressed as the mean ± the standard 
errors of the mean. P values lower than 0.05 were 
considered significant. 
 




Two important features are apparent to our present 
study. Firstly, a new series of substituted 1, 3, 5-triaryl-
2-pyrazolines have been synthesized and concluded 
that montmorrilonite K-10 clay catalyzed microwave 
assisted method as a better one with improved yields 
and shorter reaction time.  By comparing different 
inorganic solid supports, it was concluded that 
montmorillonite K-10 was the most suitable support 
for the synthesis of title compounds. Secondly, it was 
observed from the results obtained by the antimicrobial 
evaluation that compounds 4b, 4e and 4m were found 
to be the most potent compound of the series with 
antifungal activity nearly equal to that of the standard 
drug, i.e. fluconazole against A. niger and P. 
crysogenium, respectively, while compound (4j) have 
exhibited antibacterial activity nearly equal to 
reference drug i.e chloramphenicol whereas the other 
compounds show moderate to good activity. These 
results suggest that the chalcone derivatives i.e. 1, 3, 5-
trriaryl-2-pyrazolines derivatives have excellent scope 
for further development as new class of antimicrobial 
agents.  
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